STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
DFFN DIFFUSION PHARMACEUTICALS INCORPORATED StockScouter® Report
3
StockScouter® Score
DIFFUSION PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
Concerns
- The 50-day moving average for DFFN is significantly below its 200-day moving average. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
B
N/A
N/A
F